期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 16, 期 5, 页码 543-556出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.2016.1168697
关键词
Chemotherapy; surgery; different patterns of disease; survival; multidisciplinary; genomic complexity; tailored therapy; targeted drugs
类别
Osteosarcoma is the most common malignant bone tumor, currently treated with pre-and postoperative chemotherapy in association with the surgical removal of the tumor. About 15-20% of patients have evidence of metastases at diagnosis, mostly in the lungs. Patients with metastatic disease still have a very poor prognosis, with approximately 20-30% of long-term survivors, as compared with 65-70% of patients with localized disease. The optimum management of these patients has not been standardized yet due to several patterns of metastatic disease harboring different prognosis. Complete surgical resection of all sites of disease is mandatory and predictive of survival. Patients with multiple sites of disease not amenable to complete surgery removal should be considered for innovative therapeutic approaches because of poor prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据